Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: A randomized, double-blind, placebo-controlled trial

JAMA

Volumn 275, Issue 9, 1996, Pages 687-692

  Bennett Guerrero, Elliott ^a   Jimenez, John L ^a   White, William D ^a   D'Amico, Elizabeth B ^a   Baldwin, Beatrice I ^a   Schwinn, Debra A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LIOTHYRONINE;

ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROID HORMONE BLOOD LEVEL;

EID: 0029872072     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.9.687     Document Type: Article

References (55)

1. Heart and Stroke Facts: 1995 Statistical Supplement, Dallas, Tex: American Heart Association; 1995:1-23.
2. Teoh KH, Christakis GT, Weisel RD, et al. Increased risk of urgent revascularization. J Thorac Cardiovasc Surg. 1987;93:291-299.
3. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15:1261-1269.
4. Mangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anestkesiology. 1985;62:571-577.
5. Vatner SF, Baig H. Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial function and blood flow in conscious dogs with acute myocardial ischemia. Circ Res. 1979;45:793-803.
6. Disesa VJ. The rational selection of inotropic drugs in cardiac surgery. J Cardiavasc Surg. 1987; 2:385-406.
7. Levy JH, Ramsay J, Bailey JM. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothorac Vase Anestft. 1990; 4:7-11.
8. Ansell J, Tiarks C. McCue J, Parrilla N, Benotti JR. Amrinone-induced thrombocytopenia. Arch Intern. Med. 1984;144:949-952.
9. Lanza F, Beretz A, Stierle A, Hanau D, Kubina M, Cazenave J-P. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am Physiol Soc. 1988;24:H1276-H1288.
10. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
11. Schwinn DA, Leone BJ, Chesnut LC, Spahn DR, Page SO, Liggett SB. Desensitization of myocardial β-adrenergic receptors during cardiopulmonary bypass: evidence for early uncoupling and late downregulation. Circulation. 1991;84:2559-2567.
12. Bremmer WF, Taylor KM, Baird S, et al. Hypothalamo-pituitary-thyroid axis function during cardiopulmonary bypass. J Thorac Cardiovasvc Surg. 1978;75:392-399.
13. Robuschi G, Medici D, Fesani F, et al. Cardiopulmonary bypass: 'a low T4 and T3 syndrome' with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). Harm Res. 1986;23:151-158.
14. Holland FWW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a'euthyroid sick syndrome.' Ann Thorac Surg. 1991; 52:46-50.
15. Chu SH, Huang TS, Hsu RB, Wang SS, Wang CJ. Thyroid hormone changes after cardiovascular surgery and clinical implications. Ann Thorac Surg. 1991;52:791-796.
16. Mitchell IM, Pollock JCS, Jamieson MPG, Donaghey SFO'B, Paton RD, Logan RW. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg. 1992;103:800-805.
17. Goetzsche BH, Weeke J. Changes in plasma free thyroid hormones during cardiopulmonary bypass do not indicate triiodothyronine substitution. J Thorac Cardiovasc Surg. 1992;104:273-277.
18. Novitzky D, Cooper DKC, Swanepoel A. Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg. 1989;3:140-145.
19. Teiger E, Menasche P, Mansier P, et al. Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J. 1993;14:629-633.
20. Salati M, Scrofani R, Santoli C. Changes in triiodothyronine during cardiopulmonary bypass: a clinical problem? J Thorac Cardiovasc Surg. 1990; 100:464-465.
21. Palazzo MG, Suter PM. Delivery dependent oxygen consumption in patients with septic shock: daily variations, relationship with outcome and the sickeuthyroid. Intensive Care Med. 1991;17:525-332.
22. LoPresti JSS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110:970-975.
23. Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 1986;62: 717-722.
24. Chopra IJ, Hershman JM, Pardridge WM, Nicoloff JT. Thyroid function in nonthyroidal illnessess. Ann Intern Med. 1983;98:946-957.
25. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol. 1982;16:565-574.
26. Chiolero RL, Lemarchand-Beraud T, Schutz Y, de Tribolet N, Mayer-Berger M, Freeman J. Thyroid function in severely traumatized patients with or without head injury. Acta Endocrinol. 1988;117: 80-86.
27. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 1981;245:43-45.
28. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol. 1990;16: 91-95.
29. Snow TR, Deal MT, Connelly TS, Yokoyama Y, Novitzky D. Acute inotropic response of rabbit papillary muscle to triiodothyronine. Cardiology. 1992; 80:112-117.
30. Holland FW II, Brown PS Jr, Clark RE. Acute severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg. 1992;54:301-305.
31. Wechsler AS, Kadletz M, Ding M, Abd-Elfattah A, Dyke C. Effects of triiodothyronine on stunned mycoardium. J Cardiovasc Surg. 1993;8 (suppl 2):338-341.
32. Novitzky D, Human PA, Cooper DKC. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg. 1988;45: 50-55.
33. Dyke CM, Yeh T Jr, Lehman JD, et al. Triiodothyronine-enhanced left ventricular function after ischemic injury. Ann Thorac Surg. 1991;52:14-19.
34. Novitzky D, Matthews N, Shawley D, Cooper DKC, Zuhdi N. Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg. 1991;51:10-17.
35. Ririe DG, Butterworth JF, Royster RI, MacGregor DA, Zaloga GP. Triiodothyronine increases contractility independent of β-adrenergic receptors or stimulation of cyclic 3′, 5′-adenosine monophosphate. Anesthesiology. 1995;82:1004-1012.
36. Klemperer JD, Zelano J, Helm RE, et al. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg. 1995; 109:457-465.
37. Segal J. Action of the thyroid hormone at the level of the plasma membrane. Endocr Res. 1989; 15:619-649.
38. Walker JD, Crawford FA, Spinale FG. Pretreatment with 3,5,3′triiodo-L-thyronine (T3): effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming. J Thorac Cardiovasc Surg. 1995;110:315-327.
39. Novitzky D, Cooper DKC, Barton CI, et al. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg. 1989;98: 972-978.
40. Christakis GT, Weisel RD, Fremes SE, et al. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1992;103:1083-1092.
41. Royster RL, Butterworth JF IV, Prough DS, et al. Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg. 1991;72:720-736.
42. Goenen M, Jacquemart JL, Galvez S, Baele P, Robert A, Ponlot R. Preoperative left ventricular dysfunction and operative risks in coronary bypass surgery. Chest. 1992;5:804-806.
43. Sato Y, Matsuzawa H, Eguchi S. Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery. Jpn Circ J. 1982;46:1059-1069.
44. Salomon NW, Plachetka JR, Copeland JC. Comparison of dopamine and dobutamine following coronary artery bypass grafting. Ann Thorac Surg. 1982;33:43-54.
45. DiSesa VJ, Brown E, Mudge GH, Collins JJ Jr, Cohn LH. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle. J Thorac Cardiovasc Surg. 1982;83:256-263.
46. DiSesa VJ, Gold JP, Shemin RJ, Collins JJ, Cohn LH. Comparison of dopamine and dobutamine in patients requiring postoperative circulatory support. Clin Cardiol. 1986;9:253-256.
47. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med. 1994;22:1919-1925.
48. Khuri SF, Michelson AD, Valeri CR. Effects of cardiopulmonary bypass on heraostasis. In: Losealzo J, Schafer Al, eds. Thrombosis and Hemorrhage. Cambridge, Mass: Blackwell Scientific Publications; 1993:1051-1073.
49. Gersh BJ, Kronmal RA, Frye RL, et al. Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. Circulation. 1983;67:433-a91.
50. Kuan P, Bernstein SB, Ellestad MH. Coronary artery bypass surgery morbidity. J Am Coll Cardiol. 1984;3:1391-1397.
51. Hammermeister KE, Burchfiel C, Johnson R, Grover FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation. 1990;82:IV380-IV389.
52. Hannan EL, Kilburn H Jr, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State. JAMA. 1990;264:2758-2774.
53. Royster RL. Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration. J Cardiothorac Vasc Anesth. 1993;7:19-25.
54. Sterling K. Direct thyroid hormone activation of mitochondria: the role of adenine nucleotide translocase. Endocrinology. 1986;119:292-295.
55. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995;333:1522-1527.